Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06663917 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
A NA study of Hearing Impairment, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06663917 is a NA study of Hearing Impairment that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06663917, a NA study of Hearing Impairment, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is to investigate how improving place-pitch mismatch in bimodal CI users affects 1) sound quality, 2) satisfaction, and 3) speech perception.
Conditions Studied
Interventions
- OTHER Experimental frequency allocation table (FAT) - 438 Hz
- OTHER Standard FAT - 188 Hz
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-10-06 |
| Est. Completion | 2027-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06663917
The ClinicalTrials.gov registry entry for NCT06663917 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hearing Impairment appearing as the primary indexed condition, and to 2 interventions - of which Experimental frequency allocation table (FAT) - 438 Hz is the first listed.
NCT06663917 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06663917 about?
NCT06663917 is a clinical study titled "Clinical Evaluation of Frequency Allocation for Bimodal CI Users". This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is...
What is the current status of trial NCT06663917?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-10-06. Estimated completion is 2027-10-06.
What conditions does trial NCT06663917 study?
This clinical trial studies the following conditions: Hearing Impairment.
What interventions are being tested in trial NCT06663917?
The interventions under investigation include: Experimental frequency allocation table (FAT) - 438 Hz (OTHER), Standard FAT - 188 Hz (OTHER).
Who is sponsoring clinical trial NCT06663917?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06663917 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.